Similar articles

• Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?

  Hoppe UC. Hoppe UC. Clin Res Cardiol. 2007 Apr;96(4):196-8. doi: 10.1007/s00392-007-0488-x. Epub 2007 Feb 15. Clin Res Cardiol. 2007. PMID: 17294351 No abstract available.
• [Debate concerning the optimal blockage of the renin-angiotensin system].

  Choukroun G. Choukroun G. Nephrol Ther. 2010 Jan;6 Spec No 1:H1-9. doi: 10.1016/S1769-7255(10)70001-8. Nephrol Ther. 2010. PMID: 20129454 Review. French. No abstract available.
• Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?

  van der Horst IC, Voors AA, van Veldhuisen DJ. van der Horst IC, et al. Clin Res Cardiol. 2007 Apr;96(4):193-5. doi: 10.1007/s00392-007-0487-y. Epub 2007 Feb 15. Clin Res Cardiol. 2007. PMID: 17294352 Free PMC article. No abstract available.
• Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

  McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ. McMurray JJ, et al. Circulation. 2004 Nov 16;110(20):3281-8. doi: 10.1161/01.CIR.0000147274.83071.68. Circulation. 2004. PMID: 15545527 Review. No abstract available.
• Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?

  Ram CV, Deedwania PC. Ram CV, et al. Am J Cardiol. 2008 Nov 1;102(9):1281-3. doi: 10.1016/j.amjcard.2008.06.043. Epub 2008 Aug 15. Am J Cardiol. 2008. PMID: 18940307 No abstract available.